. Design of the study, critical revision.
Introduction
Intracerebral hemorrhage (ICH) accounts for approximately 10% to 15% of first-ever strokes, with a 30-day mortality rate of 35% to 52% [1] [2] . Mannitol is effective in reversing acute brain swelling. So it has been used in the management of ICH since 1960s. American Heart Association/ American
Stroke Association Stroke Council have recommended it for the management of spontaneous ICH to maintain cerebral perfusion pressure (CPP) >70 mm Hg (Class IIa, Level of Evidence B) 3 .
Mannitol is also used routinely in China. There is evidence that, in prolonged dosage, mannitol may pass might cause increased intracranial pressure 4 . There is limited scientific information about its benefit, specific thresholds and the possible mechanism in ICH [5] [6] [7] [8] [9] . Cochrane review has shown that there is currently not enough evidence to decide whether the routine use of mannitol in acute stroke would result in any beneficial or harmful effect 10 .
The present study aims at evaluating the effect of the different dosage mannitol bolus (125ml vs 250ml) on cerebral blood flow and intracranial pressure. pressures were recorded at the time of TCD examination.
Methods

This trial was conducted in Department of
Statistic analysis
Analysis was performed using the SPSS (v. 
Results
Thirty patients with ICH were enrolled within 5 days of symptom onset. The characteristics of the patients are shown in Table 1 . Table 2 . Tables 3 and 4 . 
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After 125 ml mannitol infusion, Vm in the affected MCA elevated significantly from 30min to 120min, and then decreased. Percentage showed the change of Vm and PI straightly. Figures 1 and 2 showed the tendency of Vm% and PI%. ). Anther was that some patients were older so they had some compensation space for their hematoma.
Our study showed that PI decreased just in unaffected MCA after 125ml mannitol infusion and in bilateral MCA after 250ml mannitol infusion. It suggests that 125ml mannitol decrease ICP in the uneffected hemisphere and 250ml mannitol decrease ICP in bilateral hemispheres. 250ml mannitol is more powerful in lower ICP than 125ml.
Vm of MCA is another important indicator. This study showed that mannitol infusion increased Vm of MCA significantly from 30min to 120min. The changes of Vm agreed with other studies [13] [14] . The mechanisms that mannitol increased cerebral flow velocity include: increasing blood volume, decreasing ICP ,decreasing blood viscosity, increasing erythrocyte flexibility and dilating arteriole by non-nitric oxide -dependence mechanism.
There is growing evidence that the region surrounding the hematoma is hypoperfusion [15] [16] [17] which appeared to be time dependent and correlated with the size of hematomas 18, 19 . The persistence of hypoperfusion correlated with a poor clinical outcome by day 90 and the therapeutic interventions could increase the volume of recovered perfusion 19, 20 . Our study showed that Vm increased after different dosage mannitol infusion. It maybe helpful to improve perfusion surrounding the hemorrhage, to decrease injure caused by hypoperfusion and to promote neurological functional recovery.
The difference of Vm% caused by 125ml and 250ml mannitol infusion existed from 30min to 60min. 250ml mannitol was more powerful in increasing flow velocity. So just considering effect of one dosage mannitol, 250ml was more powerful in decreaseing ICP and improving CBF.
Our result showed that there wasn't significantly difference between bilateral Vm and between bilateral PI. It didn't agree with the traditional opinion that mannitol therapy was attributed to shrinkage of the normal hemisphere rather than the side with stroke, which resulted in aggravation of midline shift 21 .
In our study one dosage mannitol (125 ml or 250 ml) infusion didn't cause pressure imbalance. Mayer study compared the difference TCD value in different size hematoma. Their result was that asymmetry of intracranial hemodynamics occurs when intracerebral hemorrhage volumes exceed 25 ml. Compared with patients with small hemorrhages, those with large hemorrhages had significantly higher affected PI (1.72 versus 1.13, P<.0001) [22] . According to their method, we also divided our patients to two groups. But there wasn't different in Vm or PI before mannitol infusion between two groups. We thought the reason was that both study were small sample, so more study was required.
Our study has some limitations. We focused on one dosage mannitol effect. How this hemadynamics change work on the long term prognosis is unknown. Further studies are required about the effect of mannitol on survival rate, disability rate, quality of life and their relationship with hemadynamic changes.
Conclusion
Mannitol infusion in patients with acute intracerebral hemorrhage can improve cerebral blood flow in bilateral hemispheres and decrease intracranial pressure in the hemorrhagic hemisphere (250ml) and in the nonhemorrhagic hemisphere (125ml and 250ml).
